Search Within

Gerd Ritter

Formats
  1. Journal Article (150)
  2. Meeting Abstract (16)
Groups
  1. Sloan Kettering Institute Postdocs (166)
  2. Department of Pathology and Laboratory Medicine (41)
  3. Department of Medicine (19)
  4. Solid Tumor Oncology Division (19)
  5. GSK Faculty (16)
  6. Melanoma and Immunotherapeutics Service (10)

More Groups

People
  1. Lloyd Old (127)
  2. Sacha Gnjatic (60)
  3. Achim Jungbluth (40)
  4. Erika Ritter (20)
  5. Leonard Cohen (16)
  6. Elisabeth Stockert (15)

More People

Years
  1. 2017 (3)
  2. 2016 (1)
  3. 2015 (2)
  4. 2014 (2)
  5. 2013 (11)
  6. 2012 (14)

More Years

Publications
  1. Proceedings of the National Academy of Sciences of the United States of America (18)
  2. Cancer Immunity (16)
  3. International Journal of Cancer (12)
  4. Cancer Research (10)
  5. Clinical Cancer Research (10)
  6. Journal of Immunology (9)

More Publications

Publishers
  1. American Association for Cancer Research (22)
  2. National Academy of Sciences (18)
  3. Academy of Cancer Immunology (16)
  4. John Wiley & Sons (12)
  5. Springer (10)
  6. The American Association of Immunologists, Inc (9)

More Publishers

Results (166)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Process development and production of cGMP grade Melan-A for cancer vaccine clinical trials
    Journal Article

    Bardliving, C. L.; Lowe, A. J.; Huang, C. J.; Manley, L.; Ritter, G.; Old, L.; Batt, C. A.
    Protein Expression and Purification (2013)

    Fulltext@MSK | Save
  • Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: A novel reagent for targeted antibody therapy of cancer
    Journal Article

    dos Santos, M. L.; Yeda, F. P.; Tsuruta, L. R.; Horta, B. B.; Pimenta, A. A. Jr; Degaki, T. L.; Soares, I. C.; Tuma, M. C.; Okamoto, O. K.; Alves, V. A. F.; more...
    PLoS ONE (2013)

    Fulltext@MSK | Save
  • NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma
    Journal Article

    Von Boehmer, L.; Mattle, M.; Bode, P.; Landshammer, A.; Schäfer, C.; Nuber, N.; Ritter, G.; Old, L.; Moch, H.; Schäfer, N.; more...
    Cancer Immunity (2013)

    Fulltext@MSK | Save
  • Antibody-based therapy in colorectal cancer
    Journal Article

    Noguchi, T.; Ritter, G.; Nishikawa, H.
    Immunotherapy (2013)

    Fulltext@MSK | Save
  • A pilot study of anti-CTLA4 antibody ipilimumab in patients with synovial sarcoma
    Journal Article

    Maki, R. G.; Jungbluth, A. A.; Gnjatic, S.; Schwartz, G. K.; D'Adamo, D. R.; Keohan, M. L.; Wagner, M. J.; Scheu, K.; Chiu, R.; Ritter, E.; more...
    Sarcoma (2013)

    Fulltext@MSK | Save
  • Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes
    Journal Article

    Hirayama, M.; Nishikawa, H.; Nagata, Y.; Tsuji, T.; Kato, T.; Kageyama, S.; Ueda, S.; Sugiyama, D.; Hori, S.; Sakaguchi, S.; more...
    European Journal of Immunology (2013)

    Fulltext@MSK | Save
  • Antibody-CpG conjugate for immunotherapy using NY-ESO-1 intracellular tumor-associated antigen target
    Meeting Abstract

    Abou, D. S.; Noguchi, T.; Ritter, G.; Lewis, J. S.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanoma
    Journal Article

    Stelter, L.; Evans, M. J.; Jungbluth, A. A.; Longo, V. A.; Zanzonico, P.; Ritter, G.; Bomalaski, J. S.; Old, L.; Larson, S. M.
    Molecular Imaging (2013)

    Fulltext@MSK | Save
  • A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy
    Journal Article

    Gupta, A.; Nuber, N.; Esslinger, C.; Wittenbrink, M.; Treder, M.; Landshammer, A.; Noguchi, T.; Kelly, M.; Gnjatic, S.; Ritter, E.; more...
    Cancer Immunity (2013)

    Fulltext@MSK | Save
  • "But Dr. Old, we already have an antibody!" Reflections on Lloyd Old's "academic biotech" approach for targeted antibodies
    Journal Article

    Ritter, G.
    Cancer Immunity (2012)

    Fulltext@MSK | Save